Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
X. Ai, S. Chao, X. Hou (Shanghai, China). 4-1BBL mediated balance of Th17/Treg in patients with allergic asthma. Eur Respir J 2012; 40: Suppl. 56, 2303

Member's Comments

No comment yet.

Related content which might interest you: 4-1BBL/4-1BB costimulation alleviates airway inflammation by restoring Treg/Th17 balance in allergic asthma Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 The potential mechanism of Th17/Treg imbalance in the microenvironments of chronic inflammation and allergic asthma Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 CD39/CD73 and the imbalance of Th17 and Tregs (regulatory T cells) in allergic asthma Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status? Source: International Congress 2017 – Monitoring asthma control Year: 2017 Relationships between glutaredoxin 1 and cytokine levels in a murine model of allergic airway inflammation Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Local cytokine profile specifics among patients with BA phenotype, associated to allergic rhinitis: allergic rhinitis and bronchial asthma. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 T-cell co-stimulatory molecules: their role in allergic immune reactions Source: Eur Respir J 2007; 29: 1246-1255 Year: 2007 Persistency of treatment response to omalizumab in patients with severe allergic (IgE-mediated) asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 CD39/CD73/A2AR pathway may involve in the occurrence allergic asthma Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Opioid-neurotensin hybrid influences pulmonary inflammatory process in murine model of non-atopic asthma. Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Chemokine-receptor expression on allergen-specific T cells in allergic asthma and allergic bronchopulmonary aspergillosis Source: Eur Respir J 2007; 30: Suppl. 51, 372s Year: 2007 IL-33 in patients with severe uncontrolled allergic asthma Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Induced sputum levels of soluble receptor ST-2 in adult patients suffering from allergic asthma or allergic rhinitis Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Study of the effect of IL-4 and IFN-γ on Th1/Th2 cells and mast cells in allergic asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001 Omalizumab improves lung function in severe persistent allergic (IgE-mediated) asthma patients: Pooled data from 5 UK centres Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012